| Primary |
| Non-small Cell Lung Cancer |
37.5% |
| Acute Myocardial Infarction |
25.0% |
| Back Pain |
25.0% |
| Hyperlipidaemia |
12.5% |
|
| Dehydration |
33.3% |
| Myalgia |
33.3% |
| Pharyngeal Ulceration |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
45.6% |
| Drug Use For Unknown Indication |
28.1% |
| Depression |
5.3% |
| Acute Myocardial Infarction |
3.5% |
| Back Pain |
3.5% |
| Osteoarthritis |
3.5% |
| Ankylosing Spondylitis |
1.8% |
| Breakthrough Pain |
1.8% |
| Musculoskeletal Pain |
1.8% |
| Pain |
1.8% |
| Post Procedural Infection |
1.8% |
| Rhinitis Allergic |
1.8% |
|
| Hepatitis |
28.6% |
| Rash |
28.6% |
| Drug-induced Liver Injury |
14.3% |
| Overdose |
14.3% |
| Pharyngeal Ulceration |
14.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.7% |
| Drug Use For Unknown Indication |
9.2% |
| Pain |
7.2% |
| Rheumatoid Arthritis |
6.8% |
| Prostate Cancer |
6.6% |
| Prophylaxis |
5.8% |
| Angina Pectoris |
5.7% |
| Cancer Pain |
5.2% |
| Nausea |
4.9% |
| Constipation |
4.5% |
| Asthma |
3.5% |
| Crohn's Disease |
3.5% |
| Hypertension |
3.5% |
| Prostate Cancer Metastatic |
3.0% |
| Ill-defined Disorder |
2.7% |
| Vomiting |
2.6% |
| Non-small Cell Lung Cancer |
2.4% |
| Arthritis |
2.2% |
| Osteoporosis |
2.2% |
| Pancreatic Carcinoma |
1.9% |
|
| Vomiting |
18.9% |
| Cerebral Ischaemia |
10.8% |
| Weight Decreased |
9.9% |
| Death |
8.1% |
| Pneumonia |
7.2% |
| Transient Ischaemic Attack |
7.2% |
| Diverticular Perforation |
4.5% |
| Pyrexia |
4.5% |
| Pulmonary Oedema |
3.6% |
| Dehydration |
2.7% |
| Pharmaceutical Product Complaint |
2.7% |
| Septic Shock |
2.7% |
| Tremor |
2.7% |
| Vascular Rupture |
2.7% |
| Vitreous Floaters |
2.7% |
| Neutropenia |
1.8% |
| Off Label Use |
1.8% |
| Pelvic Fracture |
1.8% |
| Prostate Cancer |
1.8% |
| Pulmonary Haemorrhage |
1.8% |
|
